IceCure Medical Ltd. financial data

Symbol
ICCM on Nasdaq
Location
7 Ha'eshel St., Pob 3163, Caesarea, Israel
Fiscal year end
December 31
Latest financial report
20-F - Q4 2024 - Mar 27, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56.6M shares +23.7%
Common Stock, Shares, Outstanding 58.7M shares +18.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.38M USD -44.2%
Accounts Receivable, after Allowance for Credit Loss, Current 221K USD +115%
Inventory, Net 2.33M USD +18.3%
Assets, Current 9.02M USD -32.3%
Property, Plant and Equipment, Net 1.13M USD -18.2%
Operating Lease, Right-of-Use Asset 392K USD
Assets 10.6M USD -31.1%
Accounts Payable, Current 695K USD +6.6%
Employee-related Liabilities, Current 4.17M USD
Contract with Customer, Liability, Current 334K USD +78.6%
Liabilities, Current 7.64M USD +70.5%
Operating Lease, Liability, Noncurrent 161K USD -57.2%
Liabilities 7.7M USD +62.1%
Retained Earnings (Accumulated Deficit) -112M USD -16.1%
Stockholders' Equity Attributable to Parent 2.89M USD -72.8%
Liabilities and Equity 10.6M USD -31.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 2.5B shares 0%
Common Stock, Shares, Issued 58.7M shares +18.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.38M USD -44.2%
Deferred Tax Assets, Valuation Allowance 21.7M USD +15.7%
Deferred Tax Assets, Gross 21.7M USD +15.7%
Operating Lease, Liability 459K USD -23.4%
Lessee, Operating Lease, Liability, to be Paid 529K USD -22%
Property, Plant and Equipment, Gross 2.8M USD +2.6%
Operating Lease, Liability, Current 301K USD +19.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 194K USD -24.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 304K USD +10.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 70K USD -11.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 31K USD -78.6%
Deferred Tax Assets, Operating Loss Carryforwards 21.5M USD +15.7%
Additional Paid in Capital 112M USD +9.84%